The hepatitis A vaccine protects against a viral infection of the liver that is usually spread through contaminated food or water. It is recommended for general protection, and is particularly useful for travellers to regions where hepatitis A is common, as well as individuals at higher risk of exposure.

The vaccine is typically given in two doses, six months apart, providing long-term protection. Vaccination greatly reduces your risk of hepatitis A infection and the liver illness and complications it can cause.

The hepatitis B vaccine protects against a serious liver infection caused by the hepatitis B virus, which can lead to chronic liver disease, cirrhosis and liver cancer. It is recommended for both children and adults, and especially for those with higher exposure risk through work, lifestyle or close contact.

The vaccine is usually given as a series of three doses over six months. Completing the full course offers reliable, long-term protection and helps prevent the long-term liver complications associated with the virus.

This combined vaccine protects against both hepatitis A and hepatitis B in a single course, offering convenient, comprehensive protection for the liver. It is well suited to travellers and anyone wishing to be protected against both viruses with fewer injections.

The vaccine is typically given as a series of doses over six months. It provides the same protection as the individual vaccines while reducing the number of separate appointments needed.

The HPV vaccine protects against the human papillomavirus, which can cause cervical cancer as well as other cancers and genital warts. Cervarix protects against the two high-risk types, HPV 16 and 18. Gardasil 9 offers broader protection, covering HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58 — guarding against additional cancer-causing strains as well as the types that cause genital warts, and it is suitable for both females and males.

Depending on age, the vaccine is given in two or three doses, and is most effective when given before exposure to the virus — making it especially recommended for adolescents and young adults. Vaccination significantly lowers the risk of HPV-related cancers and is an important step in long-term preventive health.

The varicella vaccine protects against chickenpox, a highly contagious infection that causes an itchy rash and fever, and can lead to complications such as skin infections and pneumonia. It is recommended for children, as well as adults who have not had chickenpox or been previously vaccinated.

The vaccine is given in two doses. Vaccination prevents chickenpox in most people and reduces the severity of illness and the risk of complications if infection does occur.

The shingles vaccine helps protect against shingles, a painful skin rash caused by the reactivation of the chickenpox virus later in life. It is recommended for older adults and those with weakened immune systems, who are at higher risk of developing the condition.

The vaccine is given according to the recommended schedule for your age and health. Vaccination lowers your risk of shingles and reduces the likelihood of long-lasting nerve pain and other complications associated with it.

The MMR vaccine provides combined protection against measles, mumps and rubella — three viral infections that can lead to serious complications such as pneumonia, meningitis and birth defects. It is recommended for children as part of routine immunisation, and for adults who are not already immune.

The vaccine is given in two doses for full protection. Vaccination offers long-term immunity and helps prevent the spread of these highly contagious diseases within the community.

The tetanus vaccine protects against tetanus, a serious bacterial infection that affects the nervous system and is often contracted through wounds or cuts. It is part of routine immunisation and is important for anyone at risk of injury.

A booster is recommended every ten years to maintain protection. Staying up to date with your tetanus vaccination helps prevent this potentially life-threatening condition.

The TDAP vaccine provides combined protection against tetanus, diphtheria and pertussis (whooping cough) — infections that can cause serious breathing, heart and neurological complications. It is recommended for adolescents and adults, and is often advised during pregnancy to protect newborns.

It is usually given as a one-time dose, followed by tetanus boosters every ten years. Vaccination offers broad protection and helps safeguard both you and those around you, including young infants.

The meningococcal vaccine protects against meningococcal disease, a serious infection that can cause meningitis and bloodstream infections. It is required for pilgrims travelling for Umrah or Hajj, and is also recommended for other travellers and individuals at higher risk.

The vaccine is given before travel, in line with entry requirements. Vaccination provides protection against this rapidly progressing and potentially life-threatening disease.

The yellow fever vaccine protects against the yellow fever virus, which is spread by mosquitoes and can cause severe illness. It is recommended for travellers to at-risk regions in Africa and South America, and proof of vaccination may be required for entry into certain countries.

A single dose provides long-lasting protection and should be given at least ten days before travel. Vaccination protects you against yellow fever and helps you meet international travel requirements.

The pneumococcal vaccine protects against pneumococcal disease, which can cause pneumonia, meningitis and bloodstream infections. It is recommended for young children, adults aged 65 and above, and individuals with chronic medical conditions or weakened immune systems.

The vaccine is given according to the recommended schedule for your age and health needs. Vaccination reduces the risk of serious pneumococcal infections and their associated complications.